Research group website - http://www.thezhulab.org/. Dr. Zhu's diverse biomedical and drug discovery research background includes a doctoral thesis studies with the inventor of Pfizer’s neurologic drug Lyrica, Prof. Richard B. Silverman, at Northwestern University, industrial research at Abbott Laboratories including participation in the discovery of AbbVie’s hepatitis C drug Viekira Pak, independent research and publication on unraveling the clinical drawbacks of BMS and Sanofi’s anti-clotting drug Plavix in self-founded laboratories, among others. These experiences have shaped Dr. Zhu’s perspectives and approaches in developing novel medicinal chemistry research programs that will provide answers to two highly imaginative questions: 1). Can we treat the human body in better accordance with its biochemical foundation? 2). Can we let the human body generate its own medicine in a targeted, selective, and more potent way?